NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN – Get Free Report) has earned an average rating of “Hold” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is C$6.46.
Several research analysts have weighed in on the stock. CIBC upped their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.75 and gave the stock a “neutral” rating in a research report on Thursday, May 16th. National Bankshares upped their price target on NorthWest Health Prop Real Est Inv Trust from C$5.25 to C$5.75 and gave the stock a “sector perform” rating in a report on Thursday, May 16th. BMO Capital Markets lifted their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$5.25 and gave the stock a “market perform” rating in a report on Monday, May 27th. Finally, Cormark raised NorthWest Health Prop Real Est Inv Trust from a “market perform” rating to a “buy” rating in a report on Thursday, March 21st.
Read Our Latest Stock Report on NWH.UN
NorthWest Health Prop Real Est Inv Trust Price Performance
NorthWest Health Prop Real Est Inv Trust Company Profile
NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
Featured Articles
- Five stocks we like better than NorthWest Health Prop Real Est Inv Trust
- How to invest in blue chip stocks
- Occidental Stock: Buffett’s 9-Day Buying Spree Lifts Stake to 29%
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3M Stock: Invest Now for Unmatched Quality and Growth Potential
- How to Invest in Biotech Stocks
- Super Micro AI Stock: Should You Invest After a 275% Increase?
Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.